Funds Will Support the SU2C Catalyst program and the Study of Small Molecule Inhibitors for Treating Cancer LOS ANGELES, March 15, 2022 /PRNewswire/ -- Stand Up To Cancer® (SU2C) and Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL) today announced that Zentalis will contribute $1 million to...
News Ticker
- [ May 19, 2022 ] Amgen celebrates 25 years of deCODE Genetics as partnership veers from discovery to development Los Angeles Biotech News
- [ May 19, 2022 ] Aseptic Technology Manager – Niagara Bottling – Diamond Bar, CA Los Angeles Biotech Jobs
- [ May 19, 2022 ] Clinical Laboratory Scientist (Generalist) – Space @ RX2 – Culver City, CA Los Angeles Biotech Jobs
- [ May 19, 2022 ] Global Health Leader and Physician, Dr. Seema Gupta Joins GATC Health Advisory Board Los Angeles Biotech News
- [ May 19, 2022 ] Director/Associate Director, Manufacturing – FUJIFILM – Thousand Oaks, CA Los Angeles Biotech Jobs
Copyright © 2021 Biotech Networks, LLC
